Role of the serine-threonine kinase PAK-1 in myxoma virus replication

Journal of Virology

Volumn 77, Issue 10, 2003, Pages 5877-5888

  Johnston, J B ^a   Barrett, John W ^a   Chang, Wen ^b   Chung, Che Sheng ^b   Zeng, Wei ^a   Masters, Jennefer ^a   Mann, Melissa ^a   Wang, Fuan ^a   Cao, Jingxin ^a,d   McFadden, Grant ^a,c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3,5 DI TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AMINO ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GENISTEIN; HERBIMYCIN A; K 252A; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; OKADAIC ACID; P21 ACTIVATED KINASE 1; PERTUSSIS TOXIN; PROTEIN KINASE INHIBITOR; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; RAPAMYCIN; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL ASSAY; CELLULAR PARAMETERS; DNA REPLICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE EXPRESSION; HOST CELL; MICROBIOLOGICAL EXAMINATION; MOUSE; MYXOMA VIRUS; NONHUMAN; PHENOTYPE; POXVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRION; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION; WESTERN BLOTTING;

3T3 CELLS; ANIMALS; CELL LINE; ENZYME ACTIVATION; ENZYME INHIBITORS; MICE; MYXOMA VIRUS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; VIRULENCE; VIRUS REPLICATION;

EID: 0038709512     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.10.5877-5888.2003     Document Type: Article

References (49)

1. Alcami, A., and U. H. Koszinowski. 2000. Viral mechanisms of immune evasion. Mol. Med. Today 6:365-372.
2. Barrett, J. W., J. X. Cao, S. Hota-Mitchell, and G. McFadden. 2001. Immunomodulatory proteins of myxoma virus. Semin. Immunol. 13:73-84.
3. Ben-Bassat, H., S. Rosenbaum-Mitrani, Z. Hartzstark, R. Levitzki, M. Chaouat, Z. Shlomai, B. Y. Klein, N. Kleinberger-Doron, A. Gazit, R. Tsvieli, and A. Levitzki. 1999. Tyrphostins that suppress the growth of human papilloma virus 16-immortalized human keratinocytes. J. Pharmacol. Exp. Ther. 290:1442-1457.
4. Bowie, A., E. Kiss-Toth, J. A. Symons, G. L. Smith, S. K. Dower, and L. A. O'Neill. 2000. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 97:10162-10167.
5. Brown, A., X. Wang, E. Sawai, and C. Cheng-Mayer. 1999. Activation of the PAK-related kinase by human immunodeficiency virus type 1 Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex. J. Virol. 73:9899-9907.
6. Cameron, C., S. Hota-Mitchell, L. Chen, J. Barrett, J. X. Cao, C. Macaulay, D. Willer, D. Evans, and G. McFadden. 1999. The complete DNA sequence of myxoma virus. Virology 264:298-318.
7. Chakrabarti, S., J. R. Sisler, and B. Moss. 1997. Compact, synthetic, vaccinia virus early/late promoter for protein expression. BioTechniques 23:1094-1097.
8. Chang, H. W., J. C. Watson, and B. L. Jacobs. 1992. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, doublestranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 89:4825-4829.
9. Davies, M. V., O. Elroy-Stein, R. Jagus, B. Moss, and R. J. Kaufman. 1992. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66:1943-1950.
10. de Magalhaes, J. C., A. A. Andrade, P. N. Silva, L. P. Sousa, C. Ropert, P. C. Ferreira, E. G. Kroon, R. T. Gazzinelli, and C. A. Bonjardim. 2001. A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. J. Biol. Chem. 276:38353-38360.
11. Esther, A., S. Iftach, and P. Esther. 1994. Inhibition of Moloney murine leukemia virus replication by tyrphostins, tyrosine kinase inhibitors. FEBS Lett. 341:99-103.
12. Fenner, F., and F. Ratcliffe. 1965. Myxomatosis. Cambridge University Press, Cambridge, United Kingdom.
13. Frischknecht, F., S. Cudmore, V. Moreau, I. Reckmann, S. Rottger, and M. Way. 1999. Tyrosine phosphorylation is required for actin-based motility of vaccinia but not Listeria or Shigella. Curr. Biol. 9:89-92.
14. Frischknecht, F., V. Moreau, S. Rottger, S. Gonfioni, I. Reckmann, G. Superti-Furga, and M. Way. 1999. Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401:926-929.
15. Garvey, T. L., J. Bertin, R. M. Siegel, G.-H. Wang, M. J. Lenardo, and J. I. Cohen. 2002. Binding of FADD and caspase-8 to molluscum contagiosum virus MC159 v-FLIP is not sufficient for its antiapoptotic function. J. Virol. 76:697-706.
16. Greber, U. F. 2002. Signalling in viral entry. Cell Mol. Life Sci. 59:608-626.
17. Hall-Jackson, C. A., M. Goedert, P. Hedge, and P. Cohen. 1999. Effect of SB 203580 on the activity of c-Raf in vitro and in vivo. Oncogene 18:2047-2054.
18. Hu, F. Q., C. A. Smith, and D. J. Pickup. 1994. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204:343-356.
19. Jaffer, Z. M., and J. Chernoff. 2002. p21-activated kinases: three more join the Pak. Int. J. Biochem. Cell Biol. 34:713-717.
20. Johnston, J. B., Y. Jiang, G. van Marle, M. B. Mayne, W. Ni, J. Holden, J. C. McArthur, and C. Power. 2000. Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity. J. Virol. 74:7211-7220.
21. Klein, N. P., M. J. Bouchard, L. H. Wang, C. Kobarg, and R. J. Schneider. 1999. Src kinases involved in hepatitis B virus replication. EMBO J. 18:5019-5027.
22. Kolch, W. 2000. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351:289-305.
23. Lalani, A. S., J. Masters, W. Zeng, J. Barrett, R. Pannu, H. Everett, C. W. Arendt, and G. McFadden. 1999. Use of chemokine receptors by poxviruses. Science 286:1968-1971.
24. Locker, J. K., A, Kuehn, S. Schleich, G. Rutter, H. Hohenberg, R. Wepf, and G. Griffiths. 2000. Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV. Mol. Biol. Cell 11:2497-2511.
25. Loparev, V. N., J. M. Parsons, J. C. Knight, J. F. Panus, C. A. Ray, R. M. Buller, D. J. Pickup, and J. J. Esposito. 1998. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl. Acad. Sci. USA 95:3786-3791.
26. Masters, J., A. A. Hinek, S. Uddin, L. C. Platanias, W. Zeng, G. McFadden, and E. N. Fish. 2001. Poxvirus infection rapidly activates tyrosine kinase signal transduction. J. Biol. Chem. 276:48371-48375.
27. Moss, B., and J. L. Shisler. 2001. Immunology 101 at poxvirus U: immune evasion genes. Semin. Immunol. 13:59-66.
28. Murata, T., F. Goshima, T. Daikoku, H. Takakuwa, and Y. Nishiyama. 2000. Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac pathway and attenuates c-Jun N-terminal kinase activation. Genes Cells 5:1017-1027.
29. Najarro, P., P. Traktman, and J. A. Lewis. 2001. Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. J. Virol. 75:3185-3196.
30. Nash, P., J. Barrett, J. X. Cao, S. Hota-Mitchell, A. S. Lalani, H. Everett, X. M. Xu, J. Robichaud, S. Hnatiuk, C. Ainslie, B. T. Seet, and G. McFadden. 1999. Immunomodulation by viruses: the myxoma virus story. Immunol. Rev. 168:103-120.
31. Nunn, M. F., and J. W. Marsh. 1996. Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J. Virol. 70:6157-6161.
32. Oie, K. L., and D. J. Pickup. 2001. Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation. Virology 288:175-187.
33. Opgenorth, A., K. Graham, N. Nation, D. Strayer, and G. McFadden. 1992. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 66:4720-4731.
34. Planz, O., S. Pleschka, and S. Ludwig. 2001. MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J. Virol. 75:4871-4877.
35. Ploegh, H. L. 1998. Viral strategies of immune evasion. Science 280:248-253.
36. Sakatsume, M., L. F. Stancato, M. David, O. Silvennoinen, P. Saharinen, J. Pierce, A. C. Larner, and D. S. Finbloom. 1998. Interferon gamma activation of Raf-1 is Jak1-dependent and p21ras-independent. J. Biol. Chem. 273:3021-3026.
37. Sells, M. A., U. G. Knaus, S. Bagrodia, D. M. Ambrose, G. M. Bokoch, and J. Chernoff. 1997. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7:202-210.
38. Shisler, J. L., and B. Moss. 2001. Molluscum contagiosum virus inhibitors of apoptosis: the MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology 282:14-25.
39. Sklan, E. H., A. Gazit, and E. Priel. 2000. Inhibition of murine AIDS (MAIDS) development in C57BL/6J mice by tyrphostin AG-1387. Virology 278:95-102.
40. Smith, G. L. 1999. Vaccinia virus immune evasion. Immunol. Lett. 65:55-62.
41. Stancato, L. F., C. R. Yu, E. F. Petricoin III, and A. C. Larner. 1998. Activation of Raf-1 by interferon gamma and oncostatin M requires expression of the Stat1 transcription factor. J. Biol. Chem. 273:18701-18704.
42. Strong, J. E., M. C. Coffey, D. Tang, P. Sabinin, and P. W. Lee. 1998. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 17:3351-3362.
43. Tzahar, E., J. D. Moyer, H. Waterman, E. G. Barbacci, J. Bao, G. Levkowitz, M, Shelly, S. Strano, R. Pinkas-Kramarski, J. H. Pierce, G. C. Andrews, and Y. Yarden. 1998. Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network. EMBO J. 17:5948-5963.
44. Wang, X., and G. P. Studzinski. 2001. Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells. Exp. Cell Res. 268:294-300.
45. Wolf, D., V. Witte, B. Laffert, K. Blume, E. Stromer, S. Trapp, P. d'Aloja, A. Schurmann, and A. S. Baur, 2001. HIV-1 Nef associated PAK and PI3kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat. Med. 7:1217-1224.
46. Wolffe, E. J., A. S. Weisberg, and B. Moss. 2001. The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. J. Virol. 75:303-310.
47. Xia, K., N. K. Mukhopadhyay, R. C. Inhorn, D. L. Barber, P. E. Rose, R. S. Lee, R. P. Narsimhan, A. D. D'Andrea, J. D. Griffin, and T. M. Roberts. 1996. The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21rasdependent manner. Proc. Natl. Acad. Sci. USA 93:11681-11686.
48. Yu, J. S., S. H. Chang, W. H. Chan, and H. C. Chen. 2001. Enzyme-linked immunosorbent assay for the determination of p21-activated kinase activity. J. Biochem. 129:243-251.
49. Yura, Y., J. Kusaka, Y. Kondo, H. Tsujimoto, H. Yoshida, and M. Sato. 1995. Inhibitory effect of tyrphostin on the replication of herpes simplex virus type 1. Arch. Virol. 140:1181-1194.